Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Mar. 31, 2012	Apr. 02, 2011
Operating activities:
Net income	$ 2,949,966	$ 1,767,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	566,157	396,318
Provision for losses on accounts receivable	(3,000)	37,202
Increase in cash value of life insurance	(162,740)	(97,784)
Deferred compensation	(26,301)	(25,326)
Stock compensation expense	36,132	33,365
Changes in operating assets and liabilities:
Accounts receivable	(4,266,489)	286,656
Inventories	2,496,888	(189,843)
Prepaid expenses and other assets	10,656	514,061
Accounts payable and accrued expenses	(420,068)	(779,322)
Net cash provided by operating activities	1,181,201	1,942,327
Investing activities:
Acquisition of M.C. Healthcare	(8,251,831)
Purchases of marketable securities		(2,000,000)
Proceeds from sale of securities available for sale	4,000,000	1,060,000
Purchases of property and equipment	(584,644)	(146,186)
Payments for other assets	(61,644)	(62,005)
Net cash used for investing activities	(4,898,119)	(1,148,191)
Financing activities:
Proceeds of long-term debt	8,800,000
Repayment of long-term debt	(6,000,000)
Dividends paid	(628,612)	(553,088)
Purchase and retirement of common stock		(8,292)
Common stock issued upon exercise of options	68,946	67,818
Net cash provided by/used for financing activities	2,240,334	(493,562)
Effect of exchange rates on cash	10
Decrease/Increase in cash and cash equivalents	(1,476,574)	300,574
Cash and cash equivalents at beginning of period	2,124,406	781,195
Cash and cash equivalents at end of period	$ 647,832	$ 1,081,769